Clinical Trial Detail

NCT ID NCT02422615
Title Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer. (MONALEESA-3)
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements yes
Sponsors Novartis Pharmaceuticals
Indications

Her2-receptor negative breast cancer

Therapies

Fulvestrant

Fulvestrant + Ribociclib

Age Groups: adult senior

Additional content available in CKB BOOST